Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116909 - 116909
Published: June 8, 2024
Lung
cancer
is
a
prevalent
malignant
tumor
and
leading
cause
of
cancer-related
fatalities
globally.
However,
current
treatments
all
have
limitations.
Therefore,
there
an
urgent
need
to
identify
readily
available
therapeutic
agent
counteract
lung
development
progression.
Luteolin
flavonoid
derived
from
vegetables
herbs
that
possesses
preventive
effects
on
various
cancers.
With
the
goal
providing
new
directions
for
treatment
cancer,
we
review
here
recent
findings
luteolin
so
as
provide
ideas
anti-lung
drugs.
The
search
focused
studies
published
between
January
1995
2024
explored
use
in
cancer.
A
comprehensive
literature
was
conducted
SCOPUS,
Google
Scholar,
PubMed,
Web
Science
databases
using
keywords
"luteolin"
"lung
cancer."
By
collecting
previous
literature,
found
has
multiple
mechanisms
effects,
including
promotion
apoptosis
cells;
inhibition
cell
proliferation,
invasion
metastasis;
modulation
immune
responses.
In
addition,
it
can
be
used
adjuvant
radio-chemotherapy
helps
ameliorate
complications.
This
summarizes
structure,
natural
sources,
physicochemical
properties
pharmacokinetics
luteolin,
focuses
mechanism
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: April 18, 2024
Abstract
Cancer,
a
complex
and
multifactorial
disease,
presents
significant
challenge
to
global
health.
Despite
advances
in
surgical,
radiotherapeutic
immunological
approaches,
which
have
improved
cancer
treatment
outcomes,
drug
therapy
continues
serve
as
key
therapeutic
strategy.
However,
the
clinical
efficacy
of
is
often
constrained
by
resistance
severe
toxic
side
effects,
thus
there
remains
critical
need
develop
novel
therapeutics.
One
promising
strategy
that
has
received
widespread
attention
recent
years
repurposing:
identification
new
applications
for
existing,
clinically
approved
drugs.
Drug
repurposing
possesses
several
inherent
advantages
context
since
repurposed
drugs
are
typically
cost-effective,
proven
be
safe,
can
significantly
expedite
development
process
due
their
already
established
safety
profiles.
In
light
this,
present
review
offers
comprehensive
overview
various
methods
employed
repurposing,
specifically
focusing
on
treat
cancer.
We
describe
antitumor
properties
candidate
drugs,
discuss
detail
how
they
target
both
hallmarks
tumor
cells
surrounding
microenvironment.
addition,
we
examine
innovative
integrating
with
nanotechnology
enhance
topical
delivery.
also
emphasize
role
play
when
used
part
combination
regimen.
To
conclude,
outline
challenges
associated
consider
future
prospects
these
transitioning
into
application.
Triple-negative
breast
cancer
(TNBC)
is
considered
as
the
most
hazardous
subtype
of
owing
to
its
accelerated
progression,
enormous
metastatic
potential,
and
refractoriness
standard
treatments.
Long
noncoding
RNAs
(lncRNAs)
are
extremely
intricate
in
tumorigenesis
cancerous
metastasis.
Nonetheless,
their
roles
initiation
augmentation
TNBC
remain
elusive.
Here,
silico
analysis
validation
experiments
were
utilized
analyze
expression
pattern
clinically
effective
lncRNAs
TNBC,
among
which
a
protective
lncRNA
LYPLAL1-DT
was
essentially
curbed
samples
indicated
favorable
prognosis.
Gain-
loss-of-function
assays
elucidated
that
considerably
attenuated
proliferative
properties
along
with
epithelial-mesenchymal
transition
cells.
Moreover,
forkhead
box
O1
(FOXO1)
validated
modulate
transcription
LYPLAL1-DT.
Mechanistically,
impinged
on
malignancy
mainly
by
restraining
aberrant
reactivation
Wnt/β-catenin
signaling
pathway,
explicitly
destabilizing
diminishing
β-catenin
protein
interacting
heterogeneous
nuclear
ribonucleoprotein
K
(hnRNPK)
constricting
formation
hnRNPK/β-catenin
complex.
Conclusively,
our
present
research
revealed
anti-oncogenic
effects
unraveling
molecular
mechanisms
FOXO1/LYPLAL1-DT/hnRNPK/β-catenin
axis,
shed
innovative
light
potential
curative
medicine
TNBC.
Cell Communication and Signaling,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 14, 2023
Abstract
Colorectal
cancer
(CRC)
is
one
of
the
most
frequent
gastrointestinal
malignancies
that
are
considered
as
a
global
health
challenge.
Despite
many
progresses
in
therapeutic
methods,
there
still
high
rate
mortality
among
CRC
patients
associated
with
poor
prognosis
and
distant
metastasis.
Therefore,
investigating
molecular
mechanisms
involved
metastasis
can
improve
prognosis.
Epithelial-mesenchymal
transition
(EMT)
process
main
metastasis,
which
be
regulated
by
various
signaling
pathways.
PI3K/AKT
pathway
has
key
role
cell
proliferation
migration.
In
present
review,
we
discussed
through
regulation
EMT
process.
It
been
shown
induce
down
epithelial
markers,
while
up
mesenchymal
markers
EMT-specific
transcription
factors
promote
This
review
an
effective
step
toward
introducing
PI3K/AKT/EMT
axis
to
predict
well
target
patients.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(19), P. 14815 - 14815
Published: Oct. 1, 2023
The
epithelial–mesenchymal
transition
(EMT)
is
a
cellular
reprogramming
process
that
occurs
during
embryonic
development
and
adult
tissue
homeostasis.
This
involves
epithelial
cells
acquiring
mesenchymal
phenotype.
Through
EMT,
cancer
acquire
properties
associated
with
more
aggressive
EMT
its
opposite,
mesenchymal–epithelial
(MET),
have
been
described
in
tumors
over
the
past
ten
years,
including
colorectal
(CRC).
When
activated,
expression
of
marker
E-cadherin
decreased
vimentin
raised.
As
result,
temporarily
take
on
phenotype,
becoming
motile
promoting
spread
tumor
cells.
Epithelial–mesenchymal
plasticity
(EMP)
has
become
hot
issue
CRC
because
strong
inducers
(such
as
transforming
growth
factor
β,
TGF-β)
can
initiate
regulate
metastasis,
microenvironment,
immune
system
resistance
CRC.
In
this
review,
we
into
account
significance
EMT-MET
impact
cells’
prognosis
analysis
connection
between
stem
(CCSCs)
will
help
to
further
clarify
current
meager
understandings
EMT.
Recent
advances
affecting
important
transcription
factors
CCSCs
are
highlighted.
We
come
conclusion
regulatory
network
for
complicated,
great
deal
crosstalk
alternate
paths.
More
thorough
research
required
effectively
connect
clinical
management
biomarkers
targeted
treatments
Experimental Hematology and Oncology,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Sept. 25, 2023
Focal
adhesion
kinase
(FAK),
a
nonreceptor
cytoplasmic
tyrosine
kinase,
is
vital
participant
in
primary
cellular
functions,
such
as
proliferation,
survival,
migration,
and
invasion.
In
addition,
FAK
regulates
cancer
stem
cell
activities
contributes
to
the
formation
of
tumor
microenvironment
(TME).
Importantly,
increased
expression
activity
are
strongly
associated
with
unfavorable
clinical
outcomes
metastatic
characteristics
numerous
tumors.
vitro
vivo
studies
have
demonstrated
that
modulating
by
application
inhibitors
alone
or
combination
treatment
regimens
could
be
effective
for
therapy.
Based
on
these
findings,
several
agents
targeting
been
exploited
diverse
preclinical
models.
This
article
briefly
describes
structure
function
FAK,
well
research
progress
therapies.
We
also
discuss
challenges
future
directions
regarding
anti-FAK
iScience,
Journal Year:
2024,
Volume and Issue:
27(6), P. 109979 - 109979
Published: May 15, 2024
This
review
explores
the
hallmarks
of
cancer
resistance,
including
drug
efflux
mediated
by
ATP-binding
cassette
(ABC)
transporters,
metabolic
reprogramming
characterized
Warburg
effect,
and
dynamic
interplay
between
cells
mitochondria.
The
role
stem
(CSCs)
in
treatment
resistance
regulatory
influence
non-coding
RNAs,
such
as
long
RNAs
(lncRNAs),
microRNAs
(miRNAs),
circular
(circRNAs),
are
studied.
chapter
emphasizes
future
directions,
encompassing
advancements
immunotherapy,
strategies
to
counter
adaptive
integration
artificial
intelligence
for
predictive
modeling,
identification
biomarkers
personalized
treatment.
comprehensive
exploration
these
provides
a
foundation
innovative
therapeutic
approaches,
aiming
navigate
complex
landscape
enhance
patient
outcomes.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
175, P. 116685 - 116685
Published: May 5, 2024
Colorectal
cancer
(CRC),
with
its
significant
incidence
and
metastatic
rates,
profoundly
affects
human
health.
A
common
oncogenic
event
in
CRC
is
the
aberrant
activation
of
Wnt/β-catenin
signalling
pathway,
which
drives
both
initiation
progression
disease.
Persistent
facilitates
epithelial-mesenchymal
transition
(EMT),
accelerates
invasion
metastasis.
This
review
provides
a
summary
recent
molecular
studies
on
role
axis
regulating
EMT
cells,
triggers
pathogenesis.
We
present
comprehensive
examination
process
transcriptional
controllers,
an
emphasis
crucial
functions
β-catenin,
transcription
factors
(EMT-TFs).
also
evidences
showing
that
hyperactive
phenotypes
via
"Destruction
complex"
β-catenin
mechanisms.
Potential
therapeutic
challenges
approache
to
suppress
prevent
cells
metastasis
by
targeting
are
discussed.
These
include
direct
inhibitors
novel
targets
Wnt
finally
highlight
potential
combinational
treatment
options
based
inhibition
pathway.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 9, 2025
Despite
enormous
progress,
advanced
cancers
are
still
one
of
the
most
serious
medical
problems
in
current
society.
Although
various
agents
and
therapeutic
strategies
with
anticancer
activity
known
used,
they
often
fail
to
achieve
satisfactory
long-term
patient
outcomes
survival.
Recently,
immunotherapy
has
shown
success
patients
by
harnessing
important
interactions
between
immune
system
cancer.
However,
many
these
therapies
lead
frequent
side
effects
when
administered
systemically,
prompting
treatment
modifications
or
discontinuation
or,
severe
cases,
fatalities.
New
approaches
like
intratumoral
immunotherapy,
characterized
reduced
effects,
cost,
systemic
toxicity,
offer
promising
prospects
for
future
applications
clinical
oncology.
In
context
locally
metastatic
cancer,
combining
diverse
immunotherapeutic
other
targeting
multiple
cancer
hallmarks
appears
crucial.
Such
combination
hold
promise
improving
survival
promoting
a
sustained
response.
This
review
aims
provide
overview
approaches,
specifically
focusing
on
administration
drugs
cancers.
It
also
explores
integration
modalities
maximize
Additionally,
summarizes
recent
advances
discusses
novel
outlining
directions
field.